Humpa, Ian Carl T.

HRN: 12-68-45  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/24/2023
CEFUROXIME 1.5GM (VIAL)
08/24/2023
08/30/2023
IVTT
810mg
Q8h
Dengue With WS, T/C Partial Obstruction
Waiting Final Action 

Indication:  Empiric    Type of Infection:  BloodstreamIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: